Sarissa Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $5.22M | Sell |
|
|||||
|
2024
Q2 | $149M | Hold |
|
|||||
|
2024
Q1 | $139M | Hold |
|
|||||
|
2023
Q4 | $166M | Hold |
|
|||||
|
2023
Q3 | $165M | Hold |
|
|||||
|
2023
Q2 | $183M | Hold |
|
|||||
|
2023
Q1 | $179M | Hold |
|
|||||
|
2022
Q4 | $178M | Hold |
|
|||||
|
2022
Q3 | $172M | Hold |
|
|||||
|
2022
Q2 | $131M | Hold |
|
|||||
|
2022
Q1 | $135M | Hold |
|
|||||
|
2021
Q4 | $154M | Hold |
|
|||||
|
2021
Q3 | $182M | Hold |
|
|||||
|
2021
Q2 | $223M | Hold |
|
|||||
|
2021
Q1 | $180M | Hold |
|
|||||
|
2020
Q4 | $157M | Hold |
|
|||||
|
2020
Q3 | $182M | Hold |
|
|||||
|
2020
Q2 | $172M | Hold |
|
|||||
|
2020
Q1 | $203M | Hold |
|
|||||
|
2019
Q4 | $191M | Hold |
|
|||||
|
2019
Q3 | $150M | Hold |
|
|||||
|
2019
Q2 | $150M | Buy |
|
|||||
|
2019
Q1 | $124M | Buy |
|
|||||
|
2018
Q4 | $139M | Hold |
|
|||||
|
2018
Q3 | $163M | Hold |
|
|||||
|
2018
Q2 | $134M | Buy |
|
|||||
|
2018
Q1 | $113M | Hold |
|
|||||
|
2017
Q4 | $132M | Buy |
|
|||||
|
2017
Q3 | $120M | Hold |
|
|||||
|
2017
Q2 | $104M | Buy |
|
|||||
|
2017
Q1 | $84.8M | Hold |
|
|||||
|
2016
Q4 | $87.9M | Hold |
|
|||||
|
2016
Q3 | $97M | Hold |
|
|||||
|
2016
Q2 | $75M | Hold |
|
|||||
|
2016
Q1 | $80.7M | Hold |
|
|||||
|
2015
Q4 | $95M | Buy |
|